News

Taking aim at a longtime target of anti-vaccine activists, CDC advisors said Thursday that the U.S. should not administer ...
The CDC's vaccine advisory committee said it will study the childhood immunization schedule in the first meeting featuring HHS Secretary RFK Jr.'s hand-selected members.
VIDEO: Annual flu, COVID and RSV vaccines among most recommended by PCP. Video 2. 01:31. VIDEO: ... Sign Up for Email. Get the latest news and education delivered to your inbox. Email address.
HealthDay News — A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. infants.. The U.S. Food and Drug Administration ...
Respiratory syncytial virus (RSV) is a leading cause of hospitalization in infants and young children, placing a significant burden on families, hospitals, and the healthcare system. Recent ...
In this video, part 2 in a 3-part series, panelists discuss clesrovimab's recent approval and gaps in clinician education. As the field of RSV prevention continues to grow, pediatricians face both new ...
MDHHS finds first active signs of West Nile virus in 2025 by: Matt Jaworowski. Posted: Jun 16, 2025 / 10:58 AM EDT. Updated: Jun 16, 2025 / 05:06 PM EDT. by: Matt Jaworowski.
Flu, COVID-19, and Respiratory Syncytial Virus (RSV): If you are ill with a respiratory virus, PLEASE STAY HOME and away from others. This will help everyone. If you are in the clinical portion of ...
Moderna receives US FDA approval for RSV vaccine, mResvia, in adults aged 18-59 at increased risk for RSV disease. News release. Moderna. June 12, 2025.
The researchers noted demographic and illness characteristics were similar between patients with RSV type A and those with RSV type B. The estimated overall seasonal incidence of outpatient ...
RELATED: Doctors Answer Your Questions About RSV. Early signs. There are signs and symptoms to look out for, but in the beginning, RSV presents with the humdrum signs of colds, flu, or COVID: runny ...
The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to 59 years old who are at increased risk for severe illness from ...